CD4 and tuberculosis: Morbidity and mortality from HIV-associated tuberculosis are slowly decreasing in Africa, mainly reflecting the expansion of HIV diagnosis and ART programmes rather than tuberculosis-specific diagnostic and prevention interventions.18, 19 Although these trends are encouraging, we found disturbingly high risk of death or microbiologically confirmed tuberculosis, or both, within 56 days of admission, despite high ART coverage and median CD4 cell count.